Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Not applicableStudy completedNCT02880189
What this trial is testing

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

Who this might be right for
ObesityNon-Alcoholic Steatohepatitis
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableWithdrawnNCT03538236
What this trial is testing

Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH

Who this might be right for
ObesityNASH - Nonalcoholic SteatohepatitisObesity, Morbid
Johns Hopkins University
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableNot Yet RecruitingNCT04925362
What this trial is testing

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
Assistance Publique - Hôpitaux de Paris 900
Large-scale testing (Phase 3)Study completedNCT00655018
What this trial is testing

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
InflammationFibrosisInsulin Resistance
Bambino Gesù Hospital and Research Institute 90
Not applicableUnknownNCT03842748
What this trial is testing

Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 300
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Testing effectiveness (Phase 2)Study completedNCT00062764
What this trial is testing

Treating Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Not applicableStudy completedNCT05370053
What this trial is testing

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Who this might be right for
Fatty LiverNAFLD
University of Kansas Medical Center 450
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Early research (Phase 1)Ended earlyNCT07052682
What this trial is testing

Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Who this might be right for
Steatohepatitis
Takeda 11
Next Page